Breaking News


Adapalene-benzoyl peroxide: A controlled study in acne vulgaris patients


A 12-week, multicenter, randomized, double-blind, parallel-group, vehicle-controlled trial of adapalene 0.1% (ADAP)/benzoyl peroxide 2.5% (BPO) gel versus the separate components was conducted in 1,670 patients with acne vulgaris. The treatments were administered once daily. The success rate was based on the frequency of patients achieving a "clear" or "almost clear" rating on the Investigator's Global Assessment (IGA). The percentage change in inflammatory lesions, noninflammatory lesions and total lesion counts was also recorded. At endpoint, the success rate was 37.9%, 21.8%, 26.7% and 17.9% in the ADAP/BPO, ADAP, BPO and placebo groups, respectively (P ≤ 0.001). The net beneficial effect of the combination was greater than the sum of the net benefits from ...

to Continue Reading, Login Now

Please Login

If you are a registered user but you have forgotten your password, please click here
If you are not a registered user, please register here

return to breaking news list